Ibogaine for Professional Boxers
Format Independent editorial guide

Screening & monitoring

The cardiac workup that determines whether this is even on the table

Most of the documented deaths associated with ibogaine trace back to inadequate screening or inadequate monitoring — not to the substance's pharmacology alone. This is the part that shouldn't be skipped or shortcut.

baseline screening and contraindications

Best practice starts with a baseline EKG, full electrolyte panel, liver function tests, and renal panels, plus pregnancy testing where relevant. This is a floor, not a formality.

Major contraindications include structural heart disease, any prior arrhythmia, a prolonged QTc, uncontrolled hypertension, severe hepatic impairment, recent stroke, and interacting medications. Any one of these should stop the conversation, not just prompt "extra caution."

Low potassium or magnesium magnifies QT prolongation risk substantially. These electrolytes must be corrected and re-confirmed before dosing — not assumed to be fine.

Medication review has to cover QT-prolonging agents and interactions via metabolism and drug transport, especially methadone and anything affecting hepatic enzymes. This review should be done by someone who understands ibogaine's specific pharmacology, not a generic intake form.

Because metabolism to noribogaine depends on CYP2D6, poor metabolizers can show atypical kinetics that affect both duration and risk. This is a real reason to test rather than guess.

Any facility considered should specify a written emergency plan and have resuscitation equipment on site, not "nearby" or "on call."

monitoring during and after dosing

Continuous cardiac monitoring with telemetry during the dosing window is what allows early detection of arrhythmia or excessive QT prolongation — before it becomes an emergency instead of after.

Subacute supervision should continue as gait and balance return to baseline. No sparring until objectively cleared, not just "feeling normal."

Hydration protocols should reverse any dehydration from travel or recent weight cutting, and electrolytes should be rechecked, not just corrected once at intake.

For a walkthrough of what a supervised session typically involves procedurally, see this primer on how ibogaine is administered in clinical settings — treat it as background, and verify specifics directly with any facility under consideration.

Aftercare should transition into a structured plan: integration therapy, sleep optimization, and a staged, monitored return to conditioning rather than jumping straight back into camp.

Clinical monitoring environment representing continuous EKG and vital checks
Continuous telemetry, not intermittent spot checks, is the standard that matters here.
Planning board representing therapy, rehydration, and conditioning benchmarks
Aftercare planning belongs on the calendar before the session, not improvised after it.

timing within a boxing season

Seasonal scheduling has to account for sanctioning calendars and media obligations, but the medical logic should drive the decision, not the reverse.

Most clinicians experienced in this space advise the off-season, with 4–6 weeks reserved for observation, integration therapy, and conditioning before any return to sparring.

Sessions should never be scheduled near planned weight cutting or travel that could produce dehydration and electrolyte loss — that combination is where the cardiac risk compounds.

Within a camp, timing needs to be mapped against sparring blocks and aerobic base periods specifically to minimize overlap with elevated-risk windows.